|
Q2 FY2026
As of Jun 27, 2026
|
Q1 FY2026
As of Mar 28, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 27, 2025
|
Q2 FY2025
As of Jun 28, 2025
|
Q1 FY2025
As of Mar 29, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 28, 2024
|
Q2 FY2024
As of Jun 29, 2024
|
Q1 FY2024
As of Mar 30, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jul 1, 2023
|
Q1 FY2023
As of Apr 1, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 24, 2022
|
Q2 FY2022
As of Jun 25, 2022
|
Q1 FY2022
As of Mar 26, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 25, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net (Note 3) | ||||||||||||||||||||
| Inventories (Note 4) | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Assets held for sale (Note 20) | ||||||||||||||||||||
| Current assets of discontinued operations (Note 2) | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net (Note 5) | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Goodwill (Note 6) | ||||||||||||||||||||
| Intangible assets, net (Note 7) | ||||||||||||||||||||
| Operating lease assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Non-current assets of discontinued operations (Note 2) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued payroll and benefits | ||||||||||||||||||||
| Accrued expenses and other current liabilities (Note 8) | ||||||||||||||||||||
| Current maturities of long-term debt (Note 10) | ||||||||||||||||||||
| Liabilities held for sale (Note 16) | ||||||||||||||||||||
| Liabilities held for sale (Note 20) | ||||||||||||||||||||
| Current liabilities of discontinued operations (Note 2) | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt (Note 10) | ||||||||||||||||||||
| Unfunded pension liability | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Deferred credits and other liabilities | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Non-current liabilities of discontinued operations (Note 2) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ (deficit) equity | ||||||||||||||||||||
| Preferred Stock, par value $0.01 per share, 90,000,000 shares authorized; no shares issued and outstanding | ||||||||||||||||||||
| Common Stock: 900,000,000 shares authorized, par value $0.01 per share, 86,610,380 and 85,489,683 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders’ (deficit) equity | ||||||||||||||||||||
| Total liabilities and shareholders’ (deficit) equity |
Loading...
